• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Turkey·Consumer Cyclical·SEGMN.IS
Share

Segmen Kardesler Gid Urt Ve Amblj Sny AS Stocks

TRY 52.65Last Updated 10.07.2026

Issuer Rating

3/7
Performance

Modest

Risk

Considerable

Recommendation

Sell

Market Cap

TRY 200.74M

TRY 52.65
Key Takeaways

Risk factor

High price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Segmen Kardesler Gida Üretim ve Ambalaj Sanayi Anonim Sirketi is a Turkish firm primarily engaged in the manufacturing and distribution of an extensive range of food items within Turkey. Its diverse product portfolio includes various types of jams, such as traditional, diabetic, sugar-free, and probiotic options. The company also provides honey, conventional and diabetic halva, peanut butter, tahini, grape molasses, and tahini molasses. Furthermore, its offerings extend to Turkish delight, a wide assortment of spices, herbal teas, and butter. Consumers can also purchase its products through online platforms. Established in 1938, the company maintains its headquarters in Ankara, Turkey.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

14.07.2026 02:42

Prosecutors from 12 U.S. states have filed a lawsuit against the Paramount-Warner Bros. Discovery deal

14.07.2026 01:22

SK Hynix Led the Decline Among Chipmakers; Oil Prices Suffered Their Sharpest One-Day Drop Since 2020

14.07.2026 00:44

Oil prices jumped by nearly 10%. The price of Brent crude exceeded $83 per barrel

14.07.2026 00:19

The top-performing stock in the S&P 500 has risen 600% this year. Evercore expects it to rise another 80%.

13.07.2026 23:47

Investors' bets on AI have bolstered the dollar. Why has this now become a risk for the currency?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026